These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24365127)

  • 1. De- and re-differentiation of the melanocytic lineage.
    Larribere L; Utikal J
    Eur J Cell Biol; 2014; 93(1-2):30-5. PubMed ID: 24365127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenotypic plasticity of neural crest-derived melanocytes and Schwann cells].
    Dupin E
    Biol Aujourdhui; 2011; 205(1):53-61. PubMed ID: 21501576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells.
    Utikal J; Maherali N; Kulalert W; Hochedlinger K
    J Cell Sci; 2009 Oct; 122(Pt 19):3502-10. PubMed ID: 19723802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocyte lineage dynamics in development, growth and disease.
    Brombin A; Patton EE
    Development; 2024 Aug; 151(15):. PubMed ID: 39092608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Melanocyte Stem Cells for Disease Modeling and Regenerative Medicine Applications.
    Mull AN; Zolekar A; Wang YC
    Int J Mol Sci; 2015 Dec; 16(12):30458-69. PubMed ID: 26703580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of novel rat and human pluripotent stem cells by reprogramming and chemical approaches.
    Li W; Ding S
    Methods Mol Biol; 2010; 636():293-300. PubMed ID: 20336530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma Progression Inhibits Pluripotency and Differentiation of Melanoma-Derived iPSCs Produces Cells with Neural-like Mixed Dysplastic Phenotype.
    Castro-Pérez E; Rodríguez CI; Mikheil D; Siddique S; McCarthy A; Newton MA; Setaluri V
    Stem Cell Reports; 2019 Jul; 13(1):177-192. PubMed ID: 31231022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
    Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
    Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of melanocyte precursors from the vertebrate neural crest.
    Dupin E; Le Douarin NM
    Oncogene; 2003 May; 22(20):3016-23. PubMed ID: 12789276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming.
    Kanawaty A; Henderson J
    Bioessays; 2009 Feb; 31(2):134-8. PubMed ID: 19204985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.
    Castro-Pérez E; Singh M; Sadangi S; Mela-Sánchez C; Setaluri V
    Pigment Cell Melanoma Res; 2023 Sep; 36(5):330-347. PubMed ID: 37132530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential PAX3 functions in normal skin melanocytes and melanoma cells.
    Medic S; Rizos H; Ziman M
    Biochem Biophys Res Commun; 2011 Aug; 411(4):832-7. PubMed ID: 21802410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From skin to other cell types of the body.
    Novak D; Weina K; Utikal J
    J Dtsch Dermatol Ges; 2014 Sep; 12(9):789-92. PubMed ID: 25087921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of Frizzled-3 and Wnt3a on melanocyte development: in vitro studies on neural crest cells and melanocyte precursor cell lines.
    Chang CH; Tsai RK; Tsai MH; Lin YH; Hirobe T
    J Dermatol Sci; 2014 Aug; 75(2):100-8. PubMed ID: 24815018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human melanocytes from induced pluripotent stem cells.
    Ohta S; Imaizumi Y; Akamatsu W; Okano H; Kawakami Y
    Methods Mol Biol; 2013; 989():193-215. PubMed ID: 23483397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the conditions for the generation of melanocytes from human embryonic stem cells.
    Fang D; Leishear K; Nguyen TK; Finko R; Cai K; Fukunaga M; Li L; Brafford PA; Kulp AN; Xu X; Smalley KS; Herlyn M
    Stem Cells; 2006 Jul; 24(7):1668-77. PubMed ID: 16574754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary de-differentiated, trans-differentiated and undifferentiated melanomas: overview of the clinicopathological, immunohistochemical and molecular spectrum.
    Ferreira I; Arends MJ; van der Weyden L; Adams DJ; Brenn T
    Histopathology; 2022 Jan; 80(1):135-149. PubMed ID: 34958502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro.
    Kuzmenkin A; Liang H; Xu G; Pfannkuche K; Eichhorn H; Fatima A; Luo H; Saric T; Wernig M; Jaenisch R; Hescheler J
    FASEB J; 2009 Dec; 23(12):4168-80. PubMed ID: 19703934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specification and loss of melanocyte stem cells.
    Robinson KC; Fisher DE
    Semin Cell Dev Biol; 2009 Feb; 20(1):111-6. PubMed ID: 19124082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The making of a melanocyte: the specification of melanoblasts from the neural crest.
    Thomas AJ; Erickson CA
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):598-610. PubMed ID: 19067969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.